Should all babies have their genomes sequenced at birth? The question has been hotly debated for the past 15 years. Unlocking the genome’s 3.2-billion-letter code promises understanding of both health ...

The goal of this workshop was to examine the types of evidence being collected as part of genomics-based programs at health care systems, consider near-term opportunities for advancing knowledge about ...

Pipeline tested on critically ill infants before rollout. Before screening healthy newborns, the team validated their analysis pipeline on 108 previously diagnosed infants, achieving over 97% ...

If you have ever welcomed a new baby into the world, you know the mix of hope and uncertainty that comes with those first days. For decades, newborn screening has been a quiet triumph of public health ...

Adding genomic sequencing to newborn blood screening would detect hundreds of additional childhood conditions, providing much earlier diagnosis and treatment, according to a new study. A baby's genome ...

‘BEACONS,’ a multi-state collaboration led by Mass General Brigham and Ariadne Labs, will enroll up to 30,000 newborns to explore adding genomic sequencing in U.S. newborn screening GAITHERSBURG, Md.- ...

In Destiny’s Child No Longer: Rewriting Genetic Fate, we envisioned a world where every newborn would be screened for genetic risks. We see a future in which the randomness of genetic inheritance ...

Plummeting costs of DNA sequencing technologies are injecting urgency into the longstanding debate over whether to dive deeper into the genomes of more infants — even apparently healthy ones. Experts ...

Adding genomic sequencing to newborn blood screening would detect hundreds of additional childhood conditions, providing much earlier diagnosis and treatment, according to a new study. A baby's genome ...

Data to be presented at the International Conference on Newborn Sequencing (ICoNS) highlighting lessons learned from the GUARDIAN and Early Check newborn sequencing studies showcasing GeneDx’s deep ...

Data from more than 22,000 newborns reinforce GeneDx’s role spearheading the adoption of genomic newborn screening (gNBS) from research to clinical practice GeneDx (Nasdaq: WGS), a leader in ...